Brevan Howard Capital Management »

Zentalis Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $110k 47k 2.34
2024-12-31 $80k 26k 3.03
2024-09-30 $57k 15k 3.68
2024-06-30 $87k 21k 4.09
2024-03-31 $214k 14k 15.76

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Pdd Holdings Sponsored Ads (PDD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr State Street Fin (XLF)
Agnc Invt Corp Com reit (AGNC)
Ishares Msci Brazil Etf (EWZ)
Meta Platforms Cl A (META)
Palantir Technologies Cl A (PLTR)

View all positions for Brevan Howard Capital Management

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
Two Sigma Investments
Renaissance Technologies
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Citadel Advisors
D. E. Shaw & Co
Opaleye Management
Decheng Capital
Millennium Management
BlackRock
Bank of America Corporation
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals